Table 2 Changes to substance use services resulting from the COVID-19 pandemic and associated safety regulationsFootnote
The data in Table 2 describe self-reported changes in services by LHDs responding to the 2021 IVP survey. LHDs selected from the displayed options to identify whether the agency modified, limited, or ended their service provision.
Service provision was modified Weighted % [95% CI] | Service was limited Weighted % [95% CI] | Service ended Weighted % [95% CI] | COVID-19 did not affect provision Weighted % [95% CI] | LHD did not provide service prior to COVID-19 Weighted % [95% CI] | n | |
|---|---|---|---|---|---|---|
Family counseling | 7 [4, 11] | 3 [1, 6] | 0 [0, 0] | 1 [0, 7] | 90 [84, 93] | 185 |
Peer navigation | 11 [7, 16] | 1 [0, 0.3] | 1 [0, 4] | 4 [2, 9] | 83 [77, 88] | 187 |
Detox programs | 4 [2, 8] | 0 [0, 1] | 0 [0, 0] | 1 [0, 4] | 94 [90, 97] | 183 |
Fentanyl testing | 5 [3, 9] | 2 [1, 6] | 0 [0, 0] | 0 [0, 1] | 92 [88, 95] | 184 |
Syringe service programs | 8 [5, 12] | 6 [3, 11] | 0 [0, 0] | 2 [1, 5] | 85 [79, 89] | 185 |
Overdose response teams | 8 [5, 13] | 5 [3, 10] | 1 [0, 4] | 2 [1, 6] | 84 [77, 88] | 184 |
Naloxone distribution, education, and/or training | 17 [12, 23] | 12 [8, 18] | 2 [1, 5] | 9 [5, 15] | 60 [52, 67] | 187 |
Peer support groups | 2 [1, 6] | 1 [0, 3] | 0 [0, 3] | 2 [1, 6] | 95 [90, 97] | 187 |
Neonatal abstinence syndrome services | 7 [4, 11] | 3 [1, 6] | 0 [0, 0] | 1 [0, 7] | 90 [84, 93] | 185 |
Linkages to care | 23 [17, 29] | 13 [9, 19] | 1 [0, 4] | 7 [4, 12] | 56 [49, 64] | 184 |
Medication for opioid use disorder: Buprenorphine, Methadone, and/or Naltrexone | 4 [2, 8] | 2 [1, 6] | 0 [0, 0] | 2 [1, 6] | 91 [86, 95] | 185 |
Community re-entry programs | 4 [2, 8] | 1 [1, 4] | 0 [0, 0] | 2 [1, 7] | 93 [88, 96] | 185 |
Community education and outreach | 21 [16, 28] | 20 [14, 26] | 5 [2, 9] | 4 [2, 8] | 50 [43, 58] | 187 |
Medication takeback events | 7 [4, 12] | 4 [2, 9] | 4 [2, 9] | 2 [1, 5] | 82 [75, 87] | 187 |
Academic detailing | 3 [2, 7] | 3 [2, 7] | 1 [0, 3] | 3 [1, 8] | 89 [84, 93] | 185 |
Housing assistance | 4 [2, 7] | 3 [2, 7] | 0 [0, 0] | 3 [1, 8] | 90 [85, 94] | 185 |
Medication for opioid use disorder: jail-based programs | 2 [1, 6] | 0 [0, 1] | 0 [0, 1] | 2 [1, 7] | 95 [90, 97] | 184 |
HIV/STI testing | 14 [10, 20] | 20 [15, 27] | 1 [0, 4] | 6 [3, 10] | 59 [52, 67] | 184 |
Anti-stigma campaigns | 10 [6, 15] | 12 [8, 18] | 3 [1, 7] | 7 [4, 11] | 68 [61, 75] | 186 |
Crisis hotline | 2 [1, 5] | 1 [0, 3] | 0 [0, 0] | 5 [2, 9] | 93 [88, 96] | 186 |
Syringe litter drop boxes | 2 [1, 5] | 5 [2, 9] | 0 [0, 0] | 7 [4, 11] | 87 [81, 91] | 184 |
Medication drop boxes | 2 [1, 6] | 4 [2, 8] | 1 [0, 3] | 9 [5, 14] | 84 [78, 89] | 187 |